🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
As a follow-on study to NCT01416038, this study is designed to identify the...
Status
Completed
Location
Winthrop University Hospital
Start Date
2013-08-23
Trial ID
NCT03332576
Treatments Being Tested
Immunotherapy is a novel way to treat cancer and does so by targeting the i...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2011-12
Trial ID
NCT01416038
Treatments Being Tested
This is a Phase 2 non-randomized, open label, uncontrolled, efficacy and sa...
Status
Completed
Location
Tom Baker Cancer Centre - Alberta Health Services
Start Date
2018-03-13
Trial ID
NCT03349450
Treatments Being Tested
This is a Phase 2b, randomized, open label study to assess the safety and e...
Status
Recruiting
Location
Compassionate Cancer Care Medical Group
Start Date
2021-06-18
Trial ID
NCT04920617
Treatments Being Tested
The study seeks to establish the safety of neoadjuvant aromatase inhibitor ...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Start Date
2021-09-10
Trial ID
NCT04895761
Treatments Being Tested
T cell activating therapy DPX-Survivac, low dose oral cyclophosphamide, and...
Status
Unknown
Location
Stanford University
Start Date
2016-04
Trial ID
NCT02785250
Treatments Being Tested
This phase 2 study was designed to assess the efficacy and safety of DPX-Su...
Status
Terminated
Location
Ottawa Hospital Research Institute
Start Date
2015-01
Trial ID
NCT02323230
Treatments Being Tested
This is a phase 2 study whose purpose is to see whether the combination of ...
Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2018-02-12
Trial ID
NCT03029403
Treatments Being Tested
This study will assess the safety and efficacy of DPX-Survivac and low dose...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center
Start Date
2018-12-21
Trial ID
NCT03836352
Treatments Being Tested
Phase 2, single arm, study to assess the efficacy and safety of maveropepim...
Status
Terminated
Location
Stanford Health Care
Start Date
2022-08-05
Trial ID
NCT05243524
Treatments Being Tested